Carlos Hernandez-Quiles (Spain)
Hospital Universitario Virgen del Rocío Internal MedicineAuthor of 2 Presentations
ANALYSIS OF THE FUNCTIONAL CAPACITY OF PATIENTS WITH ADVANCED CARDIAC AND/OR RESPIRATORY DISEASE INCLUDED IN A CLINICAL TRIAL OF TELEMONITORING OF CONSTANTS. ATLAN_TIC PROJECT.
Abstract
Background and Aims
To analyze the functional capacity of patients with advanced cardiac and/or respiratory disease included in a clinical trial of telemonitoring of constants.
Methods
Multicenter clinical trial including patients with heart failure with NYHA≥III and/or chronic respiratory failure with MRC≥III and/or oxygen saturation<90% and/or oxygen therapy.Randomization in PAC Arm (optimal standard of clinical care) and TELEPAC Arm (addition of constant telemonitoring equipment) to evaluate the requirements of hospitalization and emergency visits. Follow-up of 180 days. Secondary analysis of functional capacity using Barthel's index.
Results
510 patients from 5 hospitals were included, 255 patients in each arm. Median age was 76,5 years, being 54.5% females. Cardiac inclusion criteria were presented for 321 patients (63.1%), respiratory 71(13.9%) and 117(22.9%) both criteria.The 67.6% had multimorbility. Median score of the Charlson index of 2 points, PALIAR index of 0 points (predicting 21% mortality at 6 months) and PROFUND index of 6 points (predicting 20% mortality at one year).The analysis of functional capacity showed no initial differences (PAC 72.09+/-22.46, TELEPAC 74.6+/-22.85,p=0.32). At the end of the study, a decrease in the Barthel index was observed in the PAC arm and an increase in the TELEPAC arm (PAC 70.93+/-24.986,TELEPAC 75.41+/-24.871,p >0.05).Quality of life using the Euroqol thermometer showed an increase throughout the study with differences in favor of the TELEPAC arm (mean PAC of 56.38±21.62,TELEPAC 64.09±19.91,p < 0.01).
Conclusions
Telemonitoring in the ATLAN_TIC project meant an statistically significant increase in functional capacity, but with little clinical magnitude. Specific studies in this area are necessary.
BIOCONSTANTS IN THE MEDICAL OFFICE VERSUS HOME TELEMONITORING DEVICES. ATLAN_TIC PROJECT.
Abstract
Background and Aims
To analyze the control of bioconstants measured in the medical office versus telemonitoring in a clinical trial, in patients with advanced cardiac and/or respiratory failure.
Methods
Multicenter clinical trial including patients with heart failure with NYHA≥III and/or chronic respiratory failure with MRC≥III and/or oxygen saturation<90% and/or oxygen therapy. Randomization in PAC Arm (optimal standard of clinical care) and TELEPAC Arm (addition of constant telemonitoring equipment) to evaluate the requirements of hospitalization and emergency visits. Follow-up of 180 days. Secondary analysis of the control of bioconstants in medical office versus telemonitoring. A calibration was performed between the consultation and telemonitoring devices with a variability <5%.SSPSv20 statistical package. Approved by the Research Ethics Committee.
Results
510 patients from 5 hospitals were included, 255 patients in each arm. Median age was 76,5 years, being 54.5% females. Cardiac inclusion criteria were presented for 321 patients (63.1%), respiratory 71(13.9%) and 117(22.9%) both criteria. No differences were found in hospital admissions or emergency room visits. The median values of the biocostants measured in the medical office were: systolic blood pressure 126.77+/-30.93mmHg; diastolic blood pressure 68.53+/-8.83mmHg; heart rate 75.38+/-10.07 bpm; O2 saturation 94.82+/-2.82%; weight 79.55+/-18.47Kg. The average values of the biocostants measured with telemonitoring devices were: systolic blood pressure 120.72+/-18.63mmHg; diastolic blood pressure 68+/-9.50mmHg; heart rate 75.89+/-11.0 beats per minute; O2 saturation 93.92+/-3.48%; weight 77.69+/-19.39Kg. Differences were found in mean systolic blood pressure (PAC 126.77+/-30.93mmHg, TELEPAC 120.72+/- 8.63mmHg, p <0.05).
Conclusions
There was an adequate control of bioconstants. No differences were found in the face-to-face consultations versus telemonitoring except for systolic blood pressure.
Presenter of 1 Presentation
BIOCONSTANTS IN THE MEDICAL OFFICE VERSUS HOME TELEMONITORING DEVICES. ATLAN_TIC PROJECT.
Abstract
Background and Aims
To analyze the control of bioconstants measured in the medical office versus telemonitoring in a clinical trial, in patients with advanced cardiac and/or respiratory failure.
Methods
Multicenter clinical trial including patients with heart failure with NYHA≥III and/or chronic respiratory failure with MRC≥III and/or oxygen saturation<90% and/or oxygen therapy. Randomization in PAC Arm (optimal standard of clinical care) and TELEPAC Arm (addition of constant telemonitoring equipment) to evaluate the requirements of hospitalization and emergency visits. Follow-up of 180 days. Secondary analysis of the control of bioconstants in medical office versus telemonitoring. A calibration was performed between the consultation and telemonitoring devices with a variability <5%.SSPSv20 statistical package. Approved by the Research Ethics Committee.
Results
510 patients from 5 hospitals were included, 255 patients in each arm. Median age was 76,5 years, being 54.5% females. Cardiac inclusion criteria were presented for 321 patients (63.1%), respiratory 71(13.9%) and 117(22.9%) both criteria. No differences were found in hospital admissions or emergency room visits. The median values of the biocostants measured in the medical office were: systolic blood pressure 126.77+/-30.93mmHg; diastolic blood pressure 68.53+/-8.83mmHg; heart rate 75.38+/-10.07 bpm; O2 saturation 94.82+/-2.82%; weight 79.55+/-18.47Kg. The average values of the biocostants measured with telemonitoring devices were: systolic blood pressure 120.72+/-18.63mmHg; diastolic blood pressure 68+/-9.50mmHg; heart rate 75.89+/-11.0 beats per minute; O2 saturation 93.92+/-3.48%; weight 77.69+/-19.39Kg. Differences were found in mean systolic blood pressure (PAC 126.77+/-30.93mmHg, TELEPAC 120.72+/- 8.63mmHg, p <0.05).
Conclusions
There was an adequate control of bioconstants. No differences were found in the face-to-face consultations versus telemonitoring except for systolic blood pressure.